wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34705556-6DCE775D-F38C-4C7E-81C2-2B1BFFD8CDC8
Q34705556-6DCE775D-F38C-4C7E-81C2-2B1BFFD8CDC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34705556-6DCE775D-F38C-4C7E-81C2-2B1BFFD8CDC8
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.
P2860
Q34705556-6DCE775D-F38C-4C7E-81C2-2B1BFFD8CDC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34705556-6DCE775D-F38C-4C7E-81C2-2B1BFFD8CDC8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
15403a9aac91ac8ed76ee7ee2637f81054d3cdf4
P2860
Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.